Beamtree Holdings Ltd (ASX: BMT) Share Price and News

Mr Birch has more than 30 years of experience in implementing technological change in the healthcare industry, having previously served as Chair of the Australian Digital Health Agency, Deputy Chair of the Independent Hospital Pricing Authority, CEO of the SA Department of Health, and global healthcare leader for consulting rm EY. Jim is currently Chair of the Little Company of Mary Health Care (Calvary), and the Australian Red Cross Blood Service (now known as Lifeblood). He is the Chair of the Risk Committee.

Mr Hill is a Partner of Ernst & Young, Michael has been involved in working with management teams and boards across several companies and industries for more than 20 years. He is the MD & CIO, Founder of the Bombora Special Investment Growth Fund. Prior to Bombora he was an Investment Partner with Ironbridge, a private equity investment fund which invested $1.5bn. He is a Member of the Risk Committee.

Mr Lancken is an experienced private and public company executive with over 20 years of experience and is a Managing Partner of Liverpool Partners with former roles at Archer Capital and Seven Group Holdings Limited. Bradley has global experience in the technology and SaaS sector including currently acting as a director of Seisma and SimplyAi (technology consulting businesses), Baby Village (an ecommerce business) and former roles on the advisory board of China Media Capital Partners and iseekplant.com.au. He also has domestic health care experience, and is a director of Adora Fertility, Genea Fertility, and manages investment in Healthengine (a healthcare and GP marketplace technology company). Bradley serves the community as a Director of the NSW Institute of Sport.

Ms Gray is an experienced global business executive with over 20 years of experience in operations, strategy and digital transformation, especially in the retail, consumer and banking sectors. Emma was with ANZ Banking Group for 5 years, most recently as Group Executive, Data and Automation having previously been its Chief Data Officer. Prior to joining ANZ, Emma was a Group Executive with Woolworths, where she focused on Loyalty, Data and Strategy. Prior to executive life, Emma was a partner with Bain & Company, where she specialized in the retail and consumer segments, working across Australia, the United States and the United Kingdom for 15 years. She is a Member of Risk Committee.

Prof Hardy is Chief Executive Officer of University Hospitals Coventry and Warwickshire NHS Trust (UHCW), tertiary acute Trusts in England, with an annual turnover of 1billion pounds. Andy was appointed Chief Executive Officer in 2010. For the six years prior to that he was Chief Finance Officer of UHCW, as well as Deputy Chief Executive Officer from 2008-2010. In April 2023 he accepted the appointment of Professor for the Vice Chancellor's Health Advisory Board, Coventry University. In August 2023, Andy was appointed as Deputy Chair for the newly established National Improvement Board. Working closely with Chair, David Fillingham CBE, he leads and supports the identification and delivery of national improvement priorities in line with NHS IMPACT and associated improvement approaches.

MacDonald is a senior technology executive with more than 15 years global experience within listed software companies such as Infor Global Solutions and TechnologyOne.

-

-

-

-

-

-

-